Fexoford-M Tablet
Fexofenadine 120 mg + Montelukast 10 mg
BENEFITS
- Offers a non-sedative, second-generation, peripherally acting H1 antihistamine
- Shows early onset of action with a statistically significant suppression of wheal size compared to levocetirizine and desloratadine
- Displays built-in antileukotriene effect of Montelukast
- Improves symptom control with patient compliance
INDICATES IN
- Seasonal allergic rhinitis
- Intermittent allergic rhinitis
- Perennial allergic rhinitis
Asthma - Contact dermatitis
- Chronic idiopathic urticaria
CONTACT US
- Email: hello@email.com
- Phone/WhatsApp: +91 1234567890
- Website: www.oxpropharma.in
